Skip to content

Tag Archives: acupuncture Manatee

FDA Grants RMAT Designation to CAR T Therapy Obe-Cel for Lupus and Lupus Nephritis

FDA Grants RMAT Designation to CAR T Therapy Obe-Cel for Lupus and Lupus Nephritis

The FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to obecabtagene autoleucel (obe-cel), Autolus Therapeutics’ CAR T cell therapy, for the treatment of systemic lupus erythematosus (SLE) and lupus nephritis (LN). The designation, announced September 9, 2026, is based on Phase 1b data showing high Continue reading

Posted in Uncategorized | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on FDA Grants RMAT Designation to CAR T Therapy Obe-Cel for Lupus and Lupus Nephritis

The Russian Method: What the Research Says About Ozonated Saline IV Therapy

The Russian Method: What the Research Says About Ozonated Saline IV Therapy

Ozonated saline drips — widely known as the “Russian method” of IV ozone therapy — are having a moment of renewed scientific scrutiny. A 2025 cellular study on ozone’s anti-inflammatory effects and a 2026 published rebuttal challenging its clinical relevance have reopened debate over how this decades-old Eastern Continue reading

Posted in Uncategorized | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on The Russian Method: What the Research Says About Ozonated Saline IV Therapy

FDA Grants RMAT Designation to Personalized Stem Cell Therapy for Parkinson’s Disease

The FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to sasineprocel, Aspen Neuroscience’s investigational autologous cell therapy for Parkinson’s disease. The designation is based on encouraging early safety and activity data from the company’s ongoing Phase 1/2a ASPIRO trial.

Table of Contents What Happened How Sasineprocel Works What the Data Show Why This Matters Conclusion What Happened

On Continue reading

Posted in Uncategorized | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on FDA Grants RMAT Designation to Personalized Stem Cell Therapy for Parkinson’s Disease

Ozone Therapy Research Roundup: Wound Care, Stroke Recovery, and Cancer Support

Ozone therapy continues to draw growing peer-reviewed research interest as a complementary tool in integrative medicine. Here’s a roundup of recent notable developments spanning a new wearable delivery device, stroke recovery data, and cancer-support applications.

Table of Contents A Wearable Approach to Drug-Resistant Wounds Stroke Recovery Data Ozone as Complementary Cancer Support Faster Healing for Chronic Facial Wounds Why Continue reading

Posted in What We Treat | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on Ozone Therapy Research Roundup: Wound Care, Stroke Recovery, and Cancer Support

FDA Advisory Committee to Review Cell Therapy for Duchenne Muscular Dystrophy

The FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee meets July 29 to review Capricor Therapeutics’ deramiocel, an investigational allogeneic cell therapy for Duchenne muscular dystrophy. The meeting comes ahead of an August 22 target decision date and follows a prior rejection of the company’s first application.

Table of Contents What’s Happening How Deramiocel Works What the Data Show Why Continue reading

Posted in What We Treat | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on FDA Advisory Committee to Review Cell Therapy for Duchenne Muscular Dystrophy
941-444-6336 Directions